Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Reiss

Showing results (151-160 of 207) with videos related to

Pageof 21
Sort By:
HIV Medicine|February 9, 2008
European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIVJ D Lundgren, M Battegay, G Behrens, et al.
JAMA|April 17, 1998
A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia StudyJ S Montaner, P Reiss, D Cooper, et al.
Eclinicalmedicine|May 24, 2021
Current evidence on the adoption of indicator condition guided testing for HIV in western countries: A systematic review and meta-analysisS J Bogers, S H Hulstein, M F Schim van der Loeff, et al.
The Journal of Infectious Diseases|December 8, 1998
Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosisM Koot, R van Leeuwen, R E de Goede, et al.
Journal of Clinical Pathology|August 1, 1993
Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence techniqueT van Gool, F Snijders, P Reiss, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 7, 1998
Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agentsN G Pakker, M T Roos, R van Leeuwen, et al.
Genitourinary Medicine|December 1, 1990
Failure to maintain high-dose treatment regimens during long-term use of zidovudine in patients with symptomatic human immunodeficiency virus type 1 infectionR van Leeuwen, P J van den Hurk, G J Jöbsis, et al.
AIDS (London, England)|December 2, 1998
Estimates of the virological benefit of antiretroviral therapy are both assay- and analysis-dependentS Rae, J M Raboud, B Conway, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapyN M Ferguson, F deWolf, A C Ghani, et al.
AIDS (London, England)|October 9, 1998
Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapyJ M Raboud, J S Montaner, B Conway, et al.
Pageof 21

Showing results (151-160 of 207) with videos related to

Sort By:
Pageof 21
HIV Medicine|February 9, 2008
European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIVJ D Lundgren, M Battegay, G Behrens, et al.
JAMA|April 17, 1998
A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia StudyJ S Montaner, P Reiss, D Cooper, et al.
Eclinicalmedicine|May 24, 2021
Current evidence on the adoption of indicator condition guided testing for HIV in western countries: A systematic review and meta-analysisS J Bogers, S H Hulstein, M F Schim van der Loeff, et al.
The Journal of Infectious Diseases|December 8, 1998
Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosisM Koot, R van Leeuwen, R E de Goede, et al.
Journal of Clinical Pathology|August 1, 1993
Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence techniqueT van Gool, F Snijders, P Reiss, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 7, 1998
Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agentsN G Pakker, M T Roos, R van Leeuwen, et al.
Genitourinary Medicine|December 1, 1990
Failure to maintain high-dose treatment regimens during long-term use of zidovudine in patients with symptomatic human immunodeficiency virus type 1 infectionR van Leeuwen, P J van den Hurk, G J Jöbsis, et al.
AIDS (London, England)|December 2, 1998
Estimates of the virological benefit of antiretroviral therapy are both assay- and analysis-dependentS Rae, J M Raboud, B Conway, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapyN M Ferguson, F deWolf, A C Ghani, et al.
AIDS (London, England)|October 9, 1998
Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapyJ M Raboud, J S Montaner, B Conway, et al.
Pageof 21